Teva Women's Health, Inc.

Teva Woman's Health, Inc.

Teva Womans's Health, Inc.

Charles E DiLiberti

Lance J Bronnenkant

Kathleen Z Reape

Salah Uddin Ahmed

Anu Mahashabde

Sudhir Gorukanti

Sanjeev K Gupta

Chandra Vattikonda

Alan Liss

Sudhir R Gorukanti

The present invention is directed to methods of reducing symptoms associated with an abrupt reduction in an endogenous or exogenous chemical in subjects, the methods comprising: (a) administering to the subject a single dosage form comprising an active agent, wherein the release rate of the active agent from the single dosage form tapers throughout the administration; and (b) removing the single dosage form from the subjects after the release rate of the active agent is at or below a terminal symptom threshold level.

Methods of reducing symptoms in subjects using single dosage forms with tapering release rates

The present invention relates to an oral pharmaceutical dosage form comprising micronized progesterone, an edible oil, a disintegrant, and a hydrophilic excipient. Particularly, the invention relates to a pharmaceutical dosage form wherein the dosage form is in a powder form and is contained in a pharmaceutically acceptable capsule. The present invention is also directed toward methods of making the dosage form, methods of using the dosage form, and kits comprising the dosage form.

Oral dosage forms comprising progesterone and methods of making and using the same

The present invention provides ascending-dose extended cycle regimens in which a female is administered an estrogen and a progestin for a period of greater than 30 or 31 consecutive days, optionally followed by a hormone-free period or by a period of administration of estrogen. The disclosed regimens can be administered to a female to provide contraceptive and non-contraceptive benefits.

Methods of hormonal treatment utilizing ascending-dose extended cycle regimens

The present invention relates to methods of determining the immunogenic potential of a test product by comparing the immunogenic profile or fingerprint of the test product to the immunogenic profile or fingerprint of a reference product.

Methods for comparing the immunogenicity of products and uses thereof

Growing community of inventors

Montclair, NJ, United States of America

Charles E DiLiberti